loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Ifenprodil Tartrate

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Ifenprodil Tartrate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Algernon Reports 93% Cough Suppression With Ifenprodil
    Algernon Reports 93% Cough Suppression With Ifenprodil

    16 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/16/2913704/0/en/Algernon-Pharmaceuticals-Reports-Results-of-Study-Showing-93-Cough-Suppression-with-Ifenprodil.html

    GLOBENEWSWIRE
    16 Jul 2024
    Share Share
    Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent
    Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent

    11 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/11/2807778/0/en/Algernon-Pharmaceuticals-Announces-Notice-of-Allowance-for-Ifenprodil-Patent-in-Japan-for-Idiopathic-Pulmonary-Fibrosis.html

    GLOBENEWSWIRE
    11 Jan 2024
    Share Share
    Algernon to Present Phase 2 Ifenprodil Cough Data at Conference
    Algernon to Present Phase 2 Ifenprodil Cough Data at Conference

    06 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/06/2682659/0/en/Algernon-Pharmaceuticals-to-Present-Phase-2-Ifenprodil-Cough-Data-at-the-2023-American-Cough-Conference.html

    GLOBENEWSWIRE
    06 Jun 2023
    Share Share
    Algernon Announces Plans for 180 Patient Ph 2b Chronic Cough Study of Ifenprodil
    Algernon Announces Plans for 180 Patient Ph 2b Chronic Cough Study of Ifenprodil

    09 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/09/2585006/0/en/Algernon-Pharmaceuticals-Announces-Plans-for-a-180-Patient-Phase-2b-Chronic-Cough-Study-of-Ifenprodil.html

    GLOBENEWSWIRE
    09 Jan 2023
    Share Share
    Algernon Receives U.S. FDA Orphan Drug Designation for Ifenprodil
    Algernon Receives U.S. FDA Orphan Drug Designation for Ifenprodil

    05 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2022/12/05/2567239/0/en/Algernon-Pharmaceuticals-Receives-U-S-FDA-Orphan-Drug-Designation-for-Ifenprodil-for-the-Treatment-of-Idiopathic-Pulmonary-Fibrosis.html

    GLOBENEWSWIRE
    05 Dec 2022
    Share Share
    FDA grants orphan drug designation to Algernon's ifenprodil, exclusivity unclear
    FDA grants orphan drug designation to Algernon's ifenprodil, exclusivity unclear

    05 Dec 2022

    // Nicole DeFeudis ENDPTS

    https://endpts.com/fda-grants-orphan-drug-designation-to-algernons-ifenprodil-while-exclusivity-remains-unclear/

    Nicole DeFeudis ENDPTS
    05 Dec 2022
    Share Share